Unusual case of lamivudine-associated skin rashes in an HIV/AIDS patient: a case presentation
Kashif U Khan, Amer H Khan, Syed A Sulaiman and 2 more
Archives of Pharmacy Practice · 2017
doi:10.4103/app.app_64_16 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
In patients with human immunodeficiency virus (HIV) infection, lamivudine is used as a first-line drug for antiretroviral therapy. Lamivudine is relatively nontoxic in nature, and it can also be used during pregnancy. Herein, we describe a 43-year-old, HIV-positive female hospitalized with maculopapular, pruritic rash that appeared first on the extremities and gradually spread with systemic symptoms such as fever and myalgia after lamivudine therapy.
Abstract licence: CC BY-NC-SA
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.